Anika Gupta Vatsa, PhD
Principal
Google Ventures
GV principal investing in biotech companies developing new medicines.
Bio
Professional summary
GV describes Anthony Philippakis as a physician, genomicist, data scientist, and General Partner. His investing focus sits at the intersection of life sciences and machine learning, with a stated interest in bringing genome sequencing and data science into clinical medicine. GV notes that he spearheaded the incubation of Verve Therapeutics in 2016, working with the founding team on a gene-editing approach to heart disease. His academic and clinical background includes mathematics at Yale and Cambridge, an M.D. and Ph.D. at Harvard, and residency and cardiology fellowship training at Brigham and Women's Hospital.
Investment focus
Stage, sector, and overall fit
Stage
SeedSeries ACompany creation
Sector
Life sciencesHealthcareGenomicsMachine learning in life sciencesCardiovascular therapeutics
Thesis
Life sciences and machine learningGenome sequencing and clinical data sciencePrecision medicineHealthcare technology founders with translational science depth
Notable companies
Selected portfolio companies the partner has backed
Beacon BiosignalsBitterroot BioCardurion PharmaceuticalsDelve BioEveryONE MedicinesGenome MedicalGritstone OncologyLayer HealthMaze TherapeuticsMoonwalk BiosciencesPrudentia SciencesTenaya TherapeuticsTrace NeuroscienceVerve Therapeutics
How to approach
Framing and angles for outreach
Pitch framing
Lead with the scientific and clinical wedge: the biological insight, data advantage, translational path, and why machine learning or genomics changes what is possible in patient care. A strong pitch should connect technical rigor to a credible path toward clinical impact.
Personalization hooks
- 1Reference his cardiology and genomics background when pitching cardiovascular, precision medicine, or sequencing-enabled companies.
- 2Connect the company to practical clinical adoption, not just research novelty.
- 3Mention Verve Therapeutics only if the pitch has a serious gene-editing, cardiovascular, or precision-therapy angle.
- 4For AI healthcare pitches, emphasize validated data, workflow fit, and clinical usefulness.
Recent signals
What the partner has said or done recently
Featured in GV profile as a General Partner focused on life sciences and machine learning.
GV profile links to 2025 coverage of Prudentia Sciences launching with $7M in funding.
GV profile links to 2026 HealthCity coverage on essential hospitals and healthcare innovation.
Other partners at Google Ventures
12 more profiles
Ben Robbins
General Partner
Google Ventures
GV general partner investing in healthcare delivery and neuropsychiatric therapeutics.
Brendan Bulik-Sullivan
General Partner
Google Ventures
GV life sciences general partner with a statistical genetics and ML background.
Crystal Huang
General Partner
Google Ventures
Crystal Huang is a general partner at GV focused on SaaS, infrastructure, and AI. She has a particular interest in product-led and developer-led adoption strategies.
Dave Munichiello
Managing Partner
Google Ventures
Dave Munichiello is a Managing Partner at GV leading the firm's tech investing team across consumer, enterprise, and frontier areas.
David Krane
CEO & Managing Partner
Google Ventures
David Krane is CEO and Managing Partner at GV, where he leads global activities and invests in consumer-focused companies.
David Schenkein, MD
General Partner
Google Ventures
GV life sciences general partner and physician-investor focused on therapeutics and healthcare innovation.
Elena Sakach
Partner
Google Ventures
GV partner investing across fintech, software, and AI from the San Francisco office.
Erik Nordlander
General Partner
Google Ventures
Erik Nordlander is a general partner at GV investing in enterprise software and frontier technology. His focus areas include developer tools, cloud infrastructure, and machine learning.
FD
Frederique Dame
General Partner
Google Ventures
General Partner at GV investing across consumer, AI, life sciences, and women’s health after product leadership roles at Uber and Yahoo.
Issi Rozen
General Partner
Google Ventures
GV life sciences general partner focused on biotech company formation and early-stage investing.
Karim Faris
General Partner
Google Ventures
Karim Faris is a GV general partner investing in enterprise software, analytics, AI, and security. He has been with GV since its inception.